(Q36504371)

14 August 2017

1 reference

title

Cytokines in idiopathic inflammatory myopathies (English)

1 reference

14 August 2017

2

Ingrid E Lundberg

1 reference

14 August 2017

Stina Salomonsson

1

1 reference

14 August 2017

1 May 2006

1 reference

14 August 2017

1 reference

14 August 2017

39

1 reference

14 August 2017

3

1 reference

14 August 2017

177-190

1 reference

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

14 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Expression of immunoreactive major histocompatibility complex products in human skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Interleukin-15: a novel anabolic cytokine for skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Polymyositis: its presentation, morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

The effect of cytokines on the expression of MHC antigens and ICAM-1 by normal and transformed synoviocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Intracellular IL-1 receptor antagonist type 1 inhibits IL-1-induced cytokine production in keratinocytes through binding to the third component of the COP9 signalosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Cloning of a new cytokine that induces IFN-gamma production by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Signal transduction pathways involved in rheumatoid arthritis synovial fibroblast interleukin-18-induced vascular cell adhesion molecule-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

A proinflammatory role for IL-18 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

21 January 2018

Tumor necrosis factors.

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Tumor necrosis factor inhibits human myogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Tumor necrosis factor receptor-mediated signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Association of the proinflammatory haplotype (MICA5.1/TNF2/TNFa2/DRB1*03) with polymyositis and dermatomyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Interleukin-15: a new cytokine target for the treatment of inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Increased IL-15 production of muscle cells in polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Interleukin-15 administration improves diaphragm muscle pathology and function in dystrophic mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

HMG-1 as a late mediator of endotoxin lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Cytokines in juvenile dermatomyositis pathophysiology: potential and challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Soluble interferon-alpha receptor molecules are present in body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Interferon gamma inhibits interleukin 10 production by monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Interleukin-17 family and IL-17 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Molecular characterization of the human interleukin (IL)-17 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Endogenous interleukin 6 plays an obligatory role in interleukin 4-dependent human IgE synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Signaling mechanisms through gp130: a model of the cytokine system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Regulation of interleukin-2 and interleukin-6 production from T-cells: involvement of interleukin-1 beta and transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Induction by transforming growth factor-beta 1 of the interleukin-1 receptor antagonist and of its intracellular form in human polymorphonuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Role of biological agents in immune-mediated inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Treatment of myositis with etanercept (Enbrel), a recombinant human soluble fusion protein of TNF-alpha type II receptor and IgG1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Decreases in T-cell tumor necrosis factor alpha binding with interferon beta treatment in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Dermatomyositis after interferon alpha treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Interleukin-1? expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: Important pathogenic features independent of inflammatory cell clusters in muscl

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930600622256

10.1080/08916930600622256

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16769651